🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Hydroxychloroquine is widely used to treat autoimmune diseases. Clinical in...
Status
Completed
Location
Royal College of Surgeons in Ireland - Bahrain
Start Date
2020-08-11
Trial ID
NCT04387760
Treatments Being Tested
The present study is designed to evaluate the safety and immunogenicity of ...
Status
Completed
Location
100
Start Date
2015-04
Trial ID
NCT02427750
Treatments Being Tested
The investigators purpose is to prospectively characterize influenza infect...
Status
Completed
Location
University of Alberta Hospital
Start Date
2010-11
Trial ID
NCT01256255
Influenza virus has high morbidity rates during annual epidemics, with cert...
Status
Completed
Location
CAP Plaça Catalunya- Manresa 2
Start Date
2017-10-01
Trial ID
NCT04568785
Treatments Being Tested
This is a study to assess the immune (antibody) response and safety of a bi...
Status
Completed
Location
Site 296
Start Date
2014-08
Trial ID
NCT02214225
This randomized, open-label, active-controlled trial will assess humoral im...
Status
Completed
Location
Soroka Medical Center
Start Date
2019-10-31
Trial ID
NCT04523324
Treatments Being Tested
Prospective cohort study to evaluate safety and immunogenicity of the fragm...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02313740
Treatments Being Tested
This observational study will evaluate the safety and effectiveness followi...
Status
Completed
Location
Multiple Locations
Start Date
2009-10
Trial ID
NCT01101074
Treatments Being Tested
The observational study to get the additional data of the safety and effect...
Status
Completed
Location
Multiple Locations
Start Date
2016-10
Trial ID
NCT04413929
Treatments Being Tested
The purpose of this study is to assess the immunogenicity, safety and react...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-04-27
Trial ID
NCT04841577
Treatments Being Tested